Hoppensteadt DA - Search Results

1

Anticoagulant and antiprotease profiles of a novel natural heparinomimetic mannopentaose phosphate sulfate (PI-88).

Demir M, Iqbal O, Hoppensteadt DA, Piccolo P, Ahmad S, Schultz CL, Linhardt RJ, Fareed J. Demir M, et al. Among authors: hoppensteadt da. Clin Appl Thromb Hemost. 2001 Apr;7(2):131-40. doi: 10.1177/107602960100700210. Clin Appl Thromb Hemost. 2001. PMID: 11292191 Free article.

2

Defibrotide mediated inhibition of serotonin, endothelin-I, thromboxane, and serum induced contraction of canine femoral and pulmonary arterial rings.

Yang LH, Hoppensteadt DA, Iqbal O, Fareed J. Yang LH, et al. Among authors: hoppensteadt da. Thromb Res. 1996 Nov 1;84(3):167-77. doi: 10.1016/0049-3848(96)00173-9. Thromb Res. 1996. PMID: 8914216

3

Pharmacokinetics of low molecular weight heparins in animal models.

Fareed J, Fu K, Yang LH, Hoppensteadt DA. Fareed J, et al. Among authors: hoppensteadt da. Semin Thromb Hemost. 1999;25 Suppl 3:51-5. Semin Thromb Hemost. 1999. PMID: 10549716 Review.

4

Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies.

Ahmad S, Jeske WP, Walenga JM, Hoppensteadt DA, Wood JJ, Herbert JM, Messmore HL, Fareed J. Ahmad S, et al. Among authors: hoppensteadt da. Clin Appl Thromb Hemost. 1999 Oct;5(4):259-66. doi: 10.1177/107602969900500410. Clin Appl Thromb Hemost. 1999. PMID: 10726024 Free article.

5

Antithrombin agents: the new class of anticoagulant and antithrombotic drugs.

Fareed J, Lewis BE, Callas DD, Hoppensteadt DA, Walenga JM, Bick RL. Fareed J, et al. Among authors: hoppensteadt da. Clin Appl Thromb Hemost. 1999 Oct;5 Suppl 1:S45-55. doi: 10.1177/10760296990050s109. Clin Appl Thromb Hemost. 1999. PMID: 10726036 Free article. Review.

6

Soluble P-selectin in human plasma: effect of anticoagulant matrix and its levels in patients with cardiovascular disorders.

Amin HM, Ahmad S, Walenga JM, Hoppensteadt DA, Leitz H, Fareed J. Amin HM, et al. Among authors: hoppensteadt da. Clin Appl Thromb Hemost. 2000 Apr;6(2):71-6. doi: 10.1177/107602960000600204. Clin Appl Thromb Hemost. 2000. PMID: 10775025 Free article.

7

Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques.

Demir M, Iqbal O, Untch B, Hoppensteadt DA, Gaikwad BS, Fareed J. Demir M, et al. Among authors: hoppensteadt da. Clin Appl Thromb Hemost. 2001 Jan;7(1):38-43. doi: 10.1177/107602960100700109. Clin Appl Thromb Hemost. 2001. PMID: 11190903 Free article.

8

Anticoagulant and antiprotease effects of a novel heparinlike compound from shrimp (Penaeus brasiliensis) and its neutralization by heparinase I.

Demir M, Iqbal O, Dietrich CP, Hoppensteadt DA, Ahmad S, Daud AN, Fareed J. Demir M, et al. Among authors: hoppensteadt da. Clin Appl Thromb Hemost. 2001 Jan;7(1):44-52. doi: 10.1177/107602960100700110. Clin Appl Thromb Hemost. 2001. PMID: 11190904 Free article.

9

Influence of different anticoagulant agents on fibrinopeptide a generation.

Tobu M, Iqbal O, Messmore HL, Ma Q, Hoppensteadt DA, Fareed J. Tobu M, et al. Among authors: hoppensteadt da. Clin Appl Thromb Hemost. 2003 Oct;9(4):273-92. doi: 10.1177/107602960300900403. Clin Appl Thromb Hemost. 2003. PMID: 14653437 Free article.

10

Blood levels of nitric oxide, C-reactive protein, and tumor necrosis factor-alpha are upregulated in patients with malignancy-associated hypercoagulable state: pathophysiologic implications.

Fareed D, Iqbal O, Tobu M, Hoppensteadt DA, Fareed J. Fareed D, et al. Among authors: hoppensteadt da. Clin Appl Thromb Hemost. 2004 Oct;10(4):357-64. doi: 10.1177/107602960401000408. Clin Appl Thromb Hemost. 2004. PMID: 15497022 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters